Skip to main content
. 2001 Oct 23;2001(4):CD003159. doi: 10.1002/14651858.CD003159

GCISN 1985.

Methods multicentre, double blind, randomized, placebo controlled, parallel groups
Participants Senile cerebral insufficiency mild to moderate; 82 patients received nicergoline, 80 placebo; age > 55 yr.
Interventions Nicergoline or Placebo 20mg. twice a day (os) for 6 months
Outcomes SCAG for efficacy; adverse events for safety
Notes It describes also a crossover study but with no data available for inclusion in this review